7,376.86

+23.13

+0.31%

51,285.73

-237.33

-0.46%

24,579.42

+264.43

+1.09%

2,754.11

+24.22

+0.89%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,074.90

-38.60

-0.94%

75,639.75

-131.18

-0.17%

Crude Oil Dec 26

90.83

+0.31

+0.34%

US Private Equity

10,772.76

+11.83

+0.11%

HKSE - Delayed Quote HKD

Hangzhou Diagens Biotechnology Co., Ltd. (2526.HK)

99.850 -13.150 (-11.64%)

At close: November 6 at 4:08:50 PM GMT+8

Loading Chart for 2526.HK

Chart Range Bar

Interval:

In partnership with ChartIQ

Hangzhou Diagens Biotechnology (SEHK:2526) Stock Trades At A Premium After Medical AI Event

Hangzhou Diagens Biotechnology (SEHK:2526) Stock Trades At A Premium After Medical AI Event

World’s First Class III Approval for a Breakthrough Medical Imaging AI: Diagens AI AutoVision®

World’s First Class III Approval for a Breakthrough Medical Imaging AI: Diagens AI AutoVision®

Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine

Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine

Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine

Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine

The Next Decade of Medical AI: How Humans and AI Collaborate - A Conversation Between Kevin Kelly and Dr. Ning Song of Diagens Tech (2526. HK)

The Next Decade of Medical AI: How Humans and AI Collaborate - A Conversation Between Kevin Kelly and Dr. Ning Song of Diagens Tech (2526. HK)

Mobilize your Website

View Site in Mobile | Classic

Share by: